Sign up


Match Document Document Title
7018653 Method for preparing solid dosage form of desmopressin  
The present invention relates to a novel method for the preparation of a solid dosage form of desmopressin, or a pharmaceutically acceptable salt thereof, comprising providing a desmopressin...
7011850 Dosage forms having a barrier layer to laser ablation  
A dosage form for delivery of a therapeutic agent to a subject is described. The dosage form contains: (a) an outer wall defining an interior compartment; (b) within the interior compartment, a...
7011848 Hydrophobic component free sustained release nicotinic acid compositions for treating hyperlipidemia and related methods therefor  
An orally administered antihyperlipidemia composition according to the present invention includes from about 250 to about 3000 parts by weight of nicotinic acid, and from about 5 to about 50 parts...
7008641 Osmotic device containing venlafaxine and an anti-psychotic agent  
The present invention provides an osmotic device containing controlled release venlafaxine in the core in combination with an anti-psychotic agent in a rapid release external coat. A wide range of...
6994873 Multiparticulate formulations of lithium salts for oral administration suitable for once-a-day administration  
This invention refers to: multiparticulate formulations of Lithium salts for oral administration constituted by either modified release granules or mixtures of modified and conventional release...
6994871 Once a day antihistamine and decongestant formulation  
A controlled release pharmaceutical formulation for the administration of an antihistamine and decongestant to a patient wherein the formulation employs a compressed matrix core for the controlled...
6991807 Antibiotic composition  
Disclosed are antibiotic products for delivering at least two different antibiotics, wherein the products are comprised of at least three or four dosage forms with different release profiles and...
6989159 Pharmaceutical compositions containing lithium carbonate  
Once daily pharmaceutical compositions containing lithium carbonate in the form of coated granules.
6979468 Oral composition and method for the treatment of inflammatory cutaneous disorders  
A method and composition for the treatment of acne vulgaris, acne rosacea, and other inflammatory skin conditions comprises the oral administration of a composition comprising a dose of...
6976981 Osmotic delivery system with membrane plug retention mechanism  
An osmotic delivery system has a membrane plug retention mechanism which can also be used to control the delivery rate of a beneficial agent from the osmotic delivery system. The osmotic delivery...
6974591 Method for producing a controlled-release preparation  
The invention concerns a method for producing a controlled-release pharmaceutical preparation with a particle-containing coating, the coating being derived from an aqueous dispersion of a...
6974594 Method of preparing biological materials and preparations produced using same  
Methods for preparing products containing moisture-sensitive materials, including biological materials such as proteins, peptides or live cells, comprising at least the steps: (i) providing a...
6964780 Controlled-release pharmaceutical formulations  
The invention provides controlled-release formulations for oral administration containing a cGMP PDE-5 inhibitor. The formulations are useful, inter alia, in the treatment or prevention of sexual...
6962717 Pharmaceutical compositions  
A pharmaceutical composition for slow release of active ingredient in the gastrointestinal tract, comprising a plurality of active ingredient-containing particles coated with a material insoluble...
6960356 Orally administered drug delivery system providing temporal and spatial control  
A pharmaceutical composition in the form of tablets or capsules provides a combination of temporal and spatial control of drug delivery to a patient for effective therapeutic results. The...
6960357 Chemical delivery device  
The invention provides a controlled release dissolution and diffusion devices which can deliver an active ingredient at a constant or controlled-variable rate comprising an active ingredient and...
6958161 Modified release coated drug preparation  
A modified release preparation having one or more coated core elements, each core element including an active ingredient and having a modified release coating, wherein a stabilising coat is...
6955821 Sustained release formulations of guaifenesin and additional drug ingredients  
The invention relates to a novel pharmaceutical sustained release formulation of guaifenesin and at least one additional drug ingredient. The formulation may comprise a hydrophilic polymer,...
6953588 Multi-vitamin and mineral supplement  
This invention is directed to a multi-vitamin and mineral supplement tailored to men and post-menopausal women, pre-menopausal women, and athletes which supplies the right amount of the right...
6953586 Growth promoting pharmaceutical implant  
A combination growth promoting pharmaceutical pellet system which delivers doses of both a growth stimulating pharmaceutical agent and a supplemental agent that enhances the growth produced by the...
6933380 Excipients containing low residual solvent and method for producing the same  
The present invention provides low-residual-solvent containing excipients with residual solvent less than <3000 ppm. Most of the excipients are required to first be modified to become more water...
6932981 Rapidly disintegrating sustained release cefuroxime axetil composition  
A fast disintegrating controlled release oral composition comprising a core material containing cefuroxime axetil present as controlled release form, the cefuroxime axetil being provided with an...
6929804 Anti-fungal composition  
An anti-fungal product for delivering at least two different anti-fungals that is comprised of three dosage forms with different release profiles with each anti-fungal being present in at least one...
6926907 Pharmaceutical compositions for the coordinated delivery of NSAIDs  
The present invention is directed to drug dosage forms that release an agent that raises the pH of a patient's gastrointestinal tract, followed by a non-steroidal anti-inflammatory drug. The dosage...
6923988 Solid carriers for improved delivery of active ingredients in pharmaceutical compositions  
The present invention provides solid pharmaceutical compositions for improved delivery of a wide variety of pharmaceutical active ingredients contained therein or separately administered. In one...
6919092 Method for the management of incontinence  
A composition and a dosage form are disclosed comprising oxybutynin alone/or accompanied by another drug indicated for therapy. A method is disclosed for administering oxybutynin alone/or...
6914141 Clopidogrel bisulfate tablet formulation  
Pharmaceutical tablets comprising clopidogrel bisulfate and a lubricant selected from zinc stearate, stearic acid, and sodium stearyl fumarate.
6913767 Compositions for microencapsulation of antigens for use as vaccines  
Methods and compositions are provided for the encapsulation of antigens in PLGA microspheres for use as vaccines. Such microspheres can also contain adjuvants. Mixtures of microspheres are provided...
6913768 Sustained release delivery of amphetamine salts  
A pharmaceutical composition comprises a once-a-day sustained release formulation of at least one amphetamine salt which provides mean plasma concentration profile aspects in human ADHD patients...
6911217 Controlled release bead, a method of producing the same and multiple unit formulation comprising it  
A controlled release bead comprises: (i) a core unit of a substantially water-soluble or water-swellable inert material; (ii) a first layer on the core unit of a substantially water-insoluble...
6905707 Controlled release arginine alpha ketoglutarate  
An oral formulation of arginine α-ketoglutarate is disclosed which formulation is comprised of arginine α-ketoglutarate and one or more excipient materials. A wide range of different controlled r...
6902746 Oral pharmaceutical compositions containing non-steroidal anti-inflammatory drugs and method for preparing the same  
The present invention provides oral pharmaceutical compositions for acetic acid class of non-steroidal anti-inflammatory drug (NSAID), particularly ketorolac. The pharmaceutical composition...
6902742 Multiparticulate modified release composition  
The invention relates to a multiparticulate modified release composition that in operation delivers an active ingredient in a pulsed or bimodal manner. The multiparticulate modified release...
6899896 Hydrogel-driven layered drug dosage form  
A controlled release dosage form for sertraline has a core comprising a sertraline-containing composition and a water-swellable composition wherein the water-swellable composition is in a separate...
6893661 Controlled release formulations using intelligent polymers  
An extended release dosage composition of pharmaceutically active substances that have a water contact angle (θ) such that cos θ is between +0.9848 and −0.9848 presented as a matrix tablet con...
6890561 Microencapsulated and controlled-release formulations of isoflavone from enriched fractions of soy and other plants  
There is provided an orally-administrable formulation for the controlled release or stable storage of a granulated isoflavone-enriched fraction or mixture of such fractions, comprising at least one...
6887857 Microparticle protection of therapeutic agents  
The present invention is directed to the use of microparticles to protect the pharmaceutical effectiveness of a pharmaceutically active agent. According to one embodiment, a pharmaceutically...
6887492 Magnesium plus interactive agent delivery  
The present invention is an orally administered pharmaceutical composition that provides for the controlled release of magnesium. The composition has an interactive agent component and a magnesium...
6884433 Sustained release formulation containing tacrolimus  
Sustained release formulation containing tacrolimus or its hydrate is provided. The time (T63.2%) required for 63.2% of the maximum amount of tacrolimus or its hydrate to be dissolved is 0.7 to 15...
6875448 Method of intracellular sustained-release of drug and preparations  
A substance of interest is contained in nanospheres which are then encapsulated in fusogenic liposomes to prepare transport carriers that allow physiologically active substances, especially those...
6875446 Method for prophylaxis and/or treatment of thromboembolism  
A new oral IR formulation in solid form for a low molecular weight thrombin inhibitor having pH dependant dissolution, characterized in that the formulation comprises a filler or a combination of...
6872407 Extended release formulations of erythromycin derivatives  
Disclosed is a pharmaceutical composition for extended release of an erythromycin derivative in the gastrointestinal environment. The composition comprises an erythromycin derivative and a...
6869615 Pharmaceutical formulations containing a non-steroidal antiinflammatory drug and a proton pump inhibitor  
An oral solid dosage form includes a therapeutically effective amount of an NSAID and a proton pump inhibitor in an amount effective to inhibit or prevent gastrointestinal side effects normally...
6869976 Inorganic-polymer complexes for the controlled release of compounds including medicinals  
This invention relates generally to the production and use of inorganic-polymer complexes for the controlled release of compounds including medicinals. Advantageously, the inorganic used is calcium...
6866867 Process for preparing a directly compressible solid dosage form containing microcrystalline cellulose  
The present invention provides an improved process for the preparation of a agglomerated solid dosage form, comprising: (1) preparing an aqueous slurry of (a) microcrystalline cellulose; (b) a...
6866866 Controlled release metformin compositions  
A composition for treating patients having non-insulin-dependent diabetes mellitus (NIDDM) by administering a controlled release oral solid dosage form containing preferably a biguanide drug such...
6863902 Immediate release eplerenone compositions  
The invention relates to oral pharmaceutical compositions useful as aldosterone receptor blockers comprising the active agent micronized eplerenone in an amount of about 10 mg to about 1000 mg and...
6861072 Pharmaceutical composition with gastric residence and controlled release  
The invention concerns a pharmaceutical composition with gastric residence and controlled release, characterized in that it comprises two or three layers and contains (a) an active principle...
6855331 Sustained release hydrophobic bioactive PLGA microspheres  
A controlled release microcapsulate pharmaceutical formulation for burst-free, sustained, programmable release of hydrophobic bioactive agent over a duration from 24 hours to 100 days comprising:...
6855334 Controlled delivery of active agents  
Controlled release of active agents from sustained release push delivery devices having high drug loading are described wherein residual drug content in the device is minimized by the utilization...